PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28194442-1	2017	Canavan disease (CD) is a debilitating and lethal leukodystrophy caused by mutations in the aspartoacylase (ASPA) gene and the resulting defect in N-acetylaspartate (NAA) metabolism in the CNS and peripheral tissues.	N-acetylaspartate	147-164	cathepsin D	Mus musculus	17-19	
28194442-1	2017	Canavan disease (CD) is a debilitating and lethal leukodystrophy caused by mutations in the aspartoacylase (ASPA) gene and the resulting defect in N-acetylaspartate (NAA) metabolism in the CNS and peripheral tissues.	N-acetylaspartate	166-169	cathepsin D	Mus musculus	17-19	
14567959-1	2003	Canavan disease (CD) is an inherited leukodystrophy, caused by aspartoacylase (ASPA) deficiency, and accumulation of N-acetylaspartic acid (NAA) in the brain.	N-acetylaspartate	117-138	cathepsin D	Mus musculus	17-19	
14567959-1	2003	Canavan disease (CD) is an inherited leukodystrophy, caused by aspartoacylase (ASPA) deficiency, and accumulation of N-acetylaspartic acid (NAA) in the brain.	N-acetylaspartate	140-143	cathepsin D	Mus musculus	17-19